Pharmacokinetics and tissue penetration of fleroxacin after single and multiple 400- and 800-mg-dosage regimens.
about
Pharmacokinetics of [18F]fleroxacin in patients with acute exacerbations of chronic bronchitis and complicated urinary tract infection studied by positron emission tomography.Pharmacokinetics and biliary concentrations of fleroxacin in cholecystectomized patientsPharmacokinetics and serum bactericidal activities of quinolones in combination with clindamycin, metronidazole, and ornidazole.Treatment of genitourinary tract infections with fluoroquinolones: activity in vitro, pharmacokinetics, and clinical efficacy in urinary tract infections and prostatitis.Penetration of fleroxacin and ciprofloxacin into skin blister fluid: a comparative study.Pharmacokinetic studies of CP-74,667, a new quinolone, in laboratory animals.Pharmacokinetics of [18F]fleroxacin in healthy human subjects studied by using positron emission tomography.The pharmacokinetics of oral fleroxacin and ciprofloxacin in plasma and sputum during acute and chronic dosingDevelopment of resistance to fleroxacin during therapy of experimental methicillin-susceptible Staphylococcus aureus endocarditisComparative study of pharmacokinetics and serum bactericidal activity of ceftizoxime and cefotaxime.Pharmacokinetics of quinolones: newer aspects.Safety of fleroxacin coadministered with theophylline to young and elderly volunteersPharmacokinetics of 18F-labeled fleroxacin in rabbits with Escherichia coli infections, studied with positron emission tomography.
P2860
Q35123048-A5C8915F-A0F9-477A-869E-FD0C0D0D5DD6Q35285443-BC55D30A-F647-432C-ABEA-896F7C3D16F2Q35285981-AA7120FE-8652-45B6-AFFA-CDC3E6E35949Q35353352-6CAC2D3D-6B15-41B1-A0F9-E0A1EFDDB69EQ35867292-B32A194D-420A-4D39-B497-27E148E80DECQ35893937-896C7597-9BCB-4CAB-AD2C-66DD9A1AE5BCQ35897375-2A976717-F802-4BEE-A744-BE3D164DD53CQ36055013-47E89261-DCBA-4DA3-99D8-600F1F5364C7Q36754440-EB9A2D6E-825B-42F9-AD5A-1A1A6F830A2BQ36755784-605B536C-692B-4703-9CC9-54083EDCD4C1Q37222580-941206A8-838C-4143-B60C-B9479C99B719Q39816304-39F2D34A-53F3-45A5-8F27-9F9F9F8E9A21Q40088633-3FA48F26-C7D8-4EAA-BEBD-FE495E556173
P2860
Pharmacokinetics and tissue penetration of fleroxacin after single and multiple 400- and 800-mg-dosage regimens.
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年学术文章
@wuu
1988年学术文章
@zh-cn
1988年学术文章
@zh-hans
1988年学术文章
@zh-my
1988年学术文章
@zh-sg
1988年學術文章
@yue
1988年學術文章
@zh
1988年學術文章
@zh-hant
name
Pharmacokinetics and tissue pe ...... 0- and 800-mg-dosage regimens.
@en
Pharmacokinetics and tissue pe ...... 0- and 800-mg-dosage regimens.
@nl
type
label
Pharmacokinetics and tissue pe ...... 0- and 800-mg-dosage regimens.
@en
Pharmacokinetics and tissue pe ...... 0- and 800-mg-dosage regimens.
@nl
prefLabel
Pharmacokinetics and tissue pe ...... 0- and 800-mg-dosage regimens.
@en
Pharmacokinetics and tissue pe ...... 0- and 800-mg-dosage regimens.
@nl
P2093
P2860
P356
P1476
Pharmacokinetics and tissue pe ...... 0- and 800-mg-dosage regimens.
@en
P2093
P2860
P304
P356
10.1128/AAC.32.10.1515
P407
P577
1988-10-01T00:00:00Z